... in the combination arm had a 21 percent reduction in disease progression, compared to those who received docetaxel alone (hazard ratio, .79), and their median progression-free survival was 17.3 weeks. ...
... advanced lung cancer has continued to progress despite treatment with platinum-based and docetaxel chemotherapy.
However, in 2005, after a large international study resulted in negative findings ...
... class of drug that inhibits growth and the spread of malignant cell, similar to docetaxel, which has been the gold standard for this type of hormone independent prostate cancer. Docetaxel, however, ...
... carcinomas of the head and neck. This is the first time it has been used in combination with docetaxel and cisplatin as induction therapy.
“We found that adding cetuximab to standard chemotherapy ...
... to treatment with a class of drugs called taxanes, such as paclitaxel (Taxol) and docetaxel, that attack the dividing cells when they are trying to separate their chromosomes," says Lisa Privette, Ph ...
... models showed considerable antitumor activity both with TG2 siRNA alone and in combination with docetaxel chemotherapy. The combination therapy of TG2 siRNA with docetaxel reduced tumor weight by 86 ...
... , followed by four cycles of treatment with CMF. The remainder received an additional docetaxel treatment between the two chemotherapy stages.
At the congress, Dr. Cognetti reports results from a ...
... . 50% of breast cancer patients receiving their initial course of chemotherapy are resistant to docetaxel, and it gets worse for patients who have already had chemotherapy - 70-80% of patients who ...
... to progress despite treatment with platinum-based and docetaxel chemotherapy.
However, in 2005, a large randomized lung ... either Iressa (250 milligrams daily) or docetaxel (75 mg/m2) every three weeks ...
... II study includes 81 men with CRPC to receive either docetaxel and OGX-11 (n=40) or docetaxel alone (n=41).
"All in all, we need to move forward with the momentum and continue to let biology guide ...
... II study includes 81 men with CRPC to receive either docetaxel and OGX-11 (n=40) or docetaxel alone (n=41).
"All in all, we need to move forward with the momentum and continue to let biology guide ...
... severe infections than those treated with PF.
The authors conclude that the treatment regimen with docetaxel was superior for patients with locally advanced cancers of the larynx and hypopharynx and ...
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil during induction chemotherapy were more likely to retain larynx function than were patients ...
... other anti-cancer drugs."
In previous clinical studies, the chemotherapy drugs topotecan and docetaxel showed effectiveness when used separately against recurrent gynecologic cancers. The phase 2 ...
... . The drug combination used most commonly for patients with HER2+ breast cancer that has spread – paclitaxel or docetaxel with trastuzumab – always causes hair loss, Dr. Tan says.
All of the agents ...
